ADC Therapeutics announces series of financial moves including $175M loan from Owl Rock
ADC Therapeutics has announced a series of major strategic transactions involving hundreds of millions of…
August 16, 2022 - 3 minutes
ADC Therapeutics
Kelun-Biotech announces joint license agreement with MSD for drug targeting solid tumors
Kelun-Biotech and MSD (Merck & Co.) have announced they are entering in a joint license…
July 28, 2022 - 3 minutes
ADC Approval Buoys Spirits in Cancer Treatment Space
The FDA recently approved an antibody-drug conjugate drug from ADC Therapeutics as a treatment for…
May 11, 2021 - 7 minutes
A Year to Remember: The Biggest European Biotech News in 2020
The Covid-19 pandemic caused huge disruption for European biotech in 2020, but the industry pulled…
December 28, 2020 - 12 minutes
Update: ADC Therapeutics’ IPO Hits Above Target with €215M
Update (15/05/2020): The Swiss biotech ADC Therapeutics has priced its IPO on the New York…
May 15, 2020 - 4 minutes
ADC Therapeutics Cancels Nasdaq IPO Amidst Market Growth Fears
The Swiss biotech ADC Therapeutics has withdrawn its application for a €182M ($200M) Nasdaq IPO,…
October 4, 2019 - 2 minutes
ADC Therapeutics and SOPHiA Genetics Team Up to Personalize Cancer Treatment
Two companies based in Lausanne, Switzerland -- ADC Therapeutics and the genomics company SOPHiA Genetics…
August 6, 2019 - 2 minutes
Update: Swiss Biotech’s Series E Expanded to €271M to Commercialize Antibody-Guided Cancer Chemotherapy
Update (09/07/2019): The Switzerland-based ADC Therapeutics has completed the final closing of a €271M ($303M)…
July 9, 2019 - 3 minutes
Top 10 Biotechs in Lausanne
The Swiss city of Lausanne is perhaps best known as a hub of international sport,…
May 8, 2019 - 7 minutes
Money, Money, Money! Europe’s Best-Funded Biotechs in 2018
Besides struggling with ambitious New Year’s resolutions and post-holiday diets, January is a time where…
February 20, 2018 - 11 minutes
New Antibody-Drug Conjugate Offers Hope to Hard-to-Treat Cancer Patients
ADC Therapeutics has tested its antibody-drug conjugate technology in drug-resistant cancers, yielding encouraging results. Swiss biotech…
December 11, 2017 - 3 minutes
Europe’s Brightest Stars: The 9 Best Biotech Companies of 2017
Tis the season for Glühwein, Tannenbäume, and lights in Berlin, and Labiotech is celebrating with…
December 5, 2017 - 6 minutes
